---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-24-000165"
form_type: "8-K/A"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:38:30.219156+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pacific Biosciences estimates $27M in charges for expense reduction plan; San Diego office closure

## Summary
- Total charges estimated at $27M in fiscal 2024, including $10M compensation, $12M lease costs, $4M inventory.
- Cash expenses of ~$21M: $10M severance and benefits, $11M San Diego office closure and lease costs.
- Substantially all charges expected in Q2 and Q3 2024; company had previously disclosed plan on April 16, 2024.

## SEC filing metadata
- accession: 0001299130-24-000165
- form_type: 8-K/A
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913024000165/0001299130-24-000165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913024000165/pacb-20240416.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-24-000165
- JSON: https://secwatch.observer/filing/0001299130-24-000165.json
- Plain text: https://secwatch.observer/filing/0001299130-24-000165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.